Prosecution Insights
Last updated: August 18, 2026

Examiner: BARBER, KIMBERLY

Tech Center 3700 • Art Units: 1615 1617 1622 1626 1637 3783

This examiner grants 73% of resolved cases

Performance Statistics

73.4%
Allow Rate
+3.4% vs TC avg
102
Total Applications
+18.0%
Interview Lift
1092
Avg Prosecution Days
Based on 64 resolved cases, 2023–2026

Rejection Statute Breakdown

0.4%
§101 Eligibility
6.5%
§102 Novelty
67.2%
§103 Obviousness
18.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18800224 PEST CONTROL COMPOSITION Non-Final OA The Procter & Gamble Company
18577361 HERBICIDAL COMPOSITIONS Final Rejection SYNGENTA CROP PROTECTION AG
18711723 ANTIMICROBIAL POLYMER COMPOSITIONS, ANTIMICROBIAL POLYMER ARTICLES, AND METHODS OF MAKING THE SAME Non-Final OA CORNING INCORPORATED
18554928 OPHTHALMIC FORMULATIONS FOR SUSTAINED NEUROPROTECTION Non-Final OA The Johns Hopkins University
18090154 Compositions and methods for treating keratin materials Non-Final OA L'Oreal
18210789 Oral Compositions and Related Methods Final Rejection Colgate-Palmolive Company
18146499 MIDAZOLAM PREMIX FORMULATIONS AND USES THEREOF Non-Final OA Baxter Healthcare SA
18730010 APATITE FOR FILLER AND FILLER COMPOSITION COMPRISING SAME Non-Final OA KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
18261512 WATER-IN-OIL TYPE COMPOSITION Non-Final OA SHISEIDO COMPANY, LTD.
18474292 Implantable Medical Device for the Delivery of a Nucleic Acid Non-Final OA Celanese EVA Performance Polymers LLC
18157134 Method for Prohibiting and/or Treating an Eye Condition Final Rejection Celanese EVA Performance Polymers LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month